Albaconazole
Jump to navigation
Jump to search
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.170.829 |
Chemical and physical data | |
Formula | C20H16ClF2N5O2 |
Molar mass | 431.83 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Albaconazole (development code UR-9825) is an experimental triazole antifungal.[1] It has potential broad-spectrum activity. The drug blocks a number of CYP450 liver enzymes.[citation needed]
It has also been studied as an antiprotozoal agent.[2]
References
- ^ "Albaconazole". Adis Insight. Springer Nature Switzerland AG.
- ^ Guedes PM, Urbina JA, de Lana M, Afonso LC, Veloso VM, Tafuri WL, et al. (November 2004). "Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts". Antimicrobial Agents and Chemotherapy. 48 (11): 4286–92. doi:10.1128/AAC.48.11.4286-4292.2004. PMC 525424. PMID 15504854.
Categories:
- Articles with short description
- Short description matches Wikidata
- Drugs not assigned an ATC code
- ECHA InfoCard ID from Wikidata
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- All articles with unsourced statements
- Articles with unsourced statements from December 2022
- Chloroarenes
- Fluoroarenes
- Lactams
- Lanosterol 14α-demethylase inhibitors
- Phenylethanolamines
- Quinazolines
- Tertiary alcohols
- Triazole antifungals
- All stub articles
- Antiinfective agent stubs